Brooklyn, NY, United States of America

Abigail Lee Smenton

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abigail Lee Smenton. Retrieved from https://idiyas.com/inventor/abigail-lee-smenton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abigail Lee Smenton: Innovator in Pharmaceutical Science

Introduction

Abigail Lee Smenton is a notable inventor based in Brooklyn, NY. She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that address critical health issues.

Latest Patents

Abigail holds a patent for "Niacin receptor agonists, compositions containing such compounds and methods of treatment." This invention encompasses compounds of Formula (I) and includes pharmaceutically acceptable salts and hydrates. These compounds are useful for treating atherosclerosis, dyslipidemias, and similar conditions. The patent also covers pharmaceutical compositions and methods of use.

Career Highlights

Abigail is currently associated with Merck Sharp & Dohme Corp., where she applies her expertise in pharmaceutical research and development. Her work focuses on innovative solutions to complex health challenges.

Collaborations

Abigail has collaborated with esteemed colleagues, including Subharekha Raghavan and Steven L. Colletti, to advance her research and contribute to the scientific community.

Conclusion

Abigail Lee Smenton is a pioneering inventor whose work in pharmaceutical science is making a difference in the treatment of various health conditions. Her contributions are vital to the ongoing advancements in medical research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…